MDMA boosts PTSD therapy in quick 10-Day program
NCT ID NCT05746572
First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times
Summary
This study tests whether a single dose of MDMA, given during a 10-day intensive exposure therapy program, can improve PTSD symptoms more than therapy alone. About 40 adults with PTSD will participate at Emory University. The goal is to see if MDMA helps patients engage better with treatment and feel lasting relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PTSD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory Brain Health Center
Atlanta, Georgia, 30329, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can six short writing sessions ease PTSD in underserved patients?
- Can a psychedelic compound help veterans and first responders with PTSD and alcohol use disorder?
- Brain scans may guide psychedelics and magnetic pulses to quell suicidal thoughts
- Can online training equip therapists to tackle PTSD and addiction?
- A prescription app takes on PTSD: can digital therapy replace the couch?
- A new talk therapy aims to tackle both insomnia and PTSD in veterans